Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study (vol 59, pg 239, 2024)

被引：0
|
作者：
Ogawa, Eiichi
Jun, Dae Won
Toyoda, Hidenori
Hsu, Yao-Chun
Yoon, Eileen L.
Ahn, Sang Bong
Yeh, Ming-Lun
Do, Son
Trinh, Huy N.
Takahashi, Hirokazu
Enomoto, Masaru
Kawada, Norifumi
Yasuda, Satoshi
Tseng, Cheng-Hao
Kawashima, Keigo
Lee, Han Ah
Inoue, Kaori
Haga, Hiroaki
Do, Ai-Thien
Maeda, Mayumi
Hoang, Joseph H.
Cheung, Ramsey
Eguchi, Yuichiro
Ueno, Yoshiyuki
Furusyo, Norihiro
Yu, Ming-Lung [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Tanaka, Yasuhito
Nguyen, Mindie H.
机构：
[1] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Hepatitis Res Ctr, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Cohort Res Ctr, Kaohsiung, Taiwan
[4] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan
[5] Natl Sun Yat Sen Univ, Sch Med, Kaohsiung, Taiwan
[6] Natl Sun Yat Sen Univ, Coll Med, Doctoral Program Clin & Expt Med, Kaohsiung, Taiwan
[7] Natl Sun Yat Sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung, Taiwan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 59卷 / 05期
关键词：
D O I：
10.1111/apt.17885
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：725 / 725
页数：1
相关论文
共 50 条
  • [1] Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study
    Ogawa, Eiichi
    Jun, Dae Won
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Yoon, Eileen L.
    Ahn, Sang Bong
    Yeh, Ming-Lun
    Do, Son
    Trinh, Huy N.
    Takahashi, Hirokazu
    Enomoto, Masaru
    Kawada, Norifumi
    Yasuda, Satoshi
    Tseng, Cheng-Hao
    Kawashima, Keigo
    Lee, Han Ah
    Inoue, Kaori
    Haga, Hiroaki
    Do, Ai-Thien
    Maeda, Mayumi
    Hoang, Joseph H.
    Cheung, Ramsey
    Ueno, Yoshiyuki
    Eguchi, Yuichiro
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 239 - 248
  • [2] INCREASED TREATMENT RESPONSE AND BONE DENSITY IN PATIENTS WITH CHRONIC HEPATITIS B SWITCHED TO TENOFOVIR ALAFENAMIDE FROM OTHER NUCLEOS(T) IDE ANALOGUE: 96-WEEK RESULTS FROM A PROSPECTIVE MULTINATIONAL STUDY
    Ogawa, Eiichi
    Jun, Dae Won
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Yoon, Eileen
    Ahn, Sang Bong
    Do, Son T.
    Trinh, Huy N.
    Takahashi, Hirokazu
    Enomoto, Masaru
    Kawada, Norifumi
    Yasuda, Satoshi
    Tseng, Cheng-Hao
    Yeh, Ming-Lun
    Kawashima, Keigo
    Lee, Han Ah
    Inoue, Kaori
    Haga, Hiroaki
    Do, Ai-Thien
    Maeda, Mayumi
    Hoang, Joseph
    Cheung, Ramsey
    Ueno, Yoshiyuki
    Eguchi, Yuichiro
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie H.
    HEPATOLOGY, 2022, 76 : S281 - S282
  • [3] SEQUENTIAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) IN PATIENTS WITH CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSIS OF AN ONGOING MULTINATIONAL PROSPECTIVE STUDY
    Ogawa, Eiichi
    Toyoda, Hidenori
    Jun, Dae Won
    Hsu, Yao-Chun
    Yoon, Eileen
    Ahn, Sang Bong
    Yeh, Ming-Lun
    Yasuda, Satoshi
    Kawashima, Keigo
    Do, Son T.
    Trinh, Huy N.
    Takahashi, Hirokazu
    Enomoto, Masaru
    Tseng, Cheng-Hao
    Inoue, Kaori
    Haga, Hiroaki
    Maeda, Mayumi
    Kam, Leslie
    Cheung, Ramsey
    Ueno, Yoshiyuki
    Eguchi, Yuichiro
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie H.
    HEPATOLOGY, 2020, 72 : 495A - 496A
  • [4] Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Chang, Mimi
    Lim, Carolina
    Ahn, Alden
    Bae, Ho S.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) : 561 - 567
  • [5] Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study
    Ogawa, Eiichi
    Jun, Dae Won
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Yoon, Eileen
    Ahn, Sang Bong
    Do, Son
    Huy Trinh
    Takahashi, Hirokazu
    Enomoto, Masaru
    Yasuda, Satoshi
    Tseng, Cheng-Hao
    Yeh, Ming-Lun
    Kawashima, Keigo
    Lee, Han Ah
    Inoue, Kaori
    Haga, Hiroaki
    Ai-Thien Do
    Maeda, Mayumi
    Hoang, Joseph
    Cheung, Ramsey C.
    Ueno, Yoshiyuki
    Eguchi, Yuichiro
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie
    JOURNAL OF HEPATOLOGY, 2022, 77 : S875 - S876
  • [6] IMPROVEMENT OF BONE MINERAL DENSITY AND MARKERS OF PROXIMAL RENAL TUBULAR FUNCTION IN 12 WEEKS IN CHRONIC HEPATITIS B PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Le, Justin
    Ahn, Aiden
    Kim, Carolina
    Chang, Mimi
    Bae, Ho
    GASTROENTEROLOGY, 2018, 154 (06) : S1133 - S1134
  • [7] Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study
    Zeng, Qing-Lei
    Zhang, Hong-Xu
    Zhang, Ji-Yuan
    Huang, Shuo
    Li, Wei-Zhe
    Li, Guang-Ming
    Pan, Ya-Jie
    Feng, Ying-Hua
    Li, Zhi-Qin
    Zhang, Guo-Fan
    Xu, Jiang-Hai
    Lin, Wan-Bao
    Xu, Guang-Hua
    Liu, Na
    Zhang, Guo-Qiang
    Li, Guo-Tao
    Li, Wei
    Zeng, Yan-Li
    Song, Ning
    Wang, Meng
    Zhang, Da-Wei
    Chen, Zhi-Min
    Cui, Guang-Lin
    Li, Juan
    Lv, Jun
    Liu, Yan-Min
    Liang, Hong-Xia
    Sun, Chang-Yu
    Zhou, Yi-Hua
    Yu, Zu-Jiang
    Wang, Fu-Sheng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (12) : 2826 - +
  • [8] Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection (vol 10, pg 707, 2017)
    Abdul, Basit S.
    Dawood, A.
    Ryan, J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (09) : 1021 - 1021
  • [9] Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA (vol 54, pg 877, 2024)
    Yamada, S.
    Uchida, Y.
    Kouyama, J., I
    HEPATOLOGY RESEARCH, 2025,
  • [10] Smaller decreases in bone mineral density in chronic hepatitis B patients receiving tenofovir alafenamide compared with tenofovir disoproxil fumarate over 96 weeks
    Fung, S.
    Chuang, W. L.
    Nishiguchi, S.
    Seto, W. K.
    Tak, W. Y.
    Erne, E. M.
    Jablkowski, M.
    Morozov, V.
    Lau, A. H.
    Suri, V.
    Flaherty, J. F.
    Kim, K.
    Gaggar, A.
    Subramanian, G. M.
    Celen, M.
    Lim, S-G
    Chan, H. L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S691 - S692
12345